Market Overview The global Camylofin Market was valued at US$ 445.08 million in 2025 and is expected to reach US$ 677.66 million by 2034. The market is estimated to register a CAGR of 4.78% during 2026–2034. Camylofin plays an established role in the management of spasmodic pain associated with gastrointestinal, biliary, urinary, and gynecological conditions. By helping relax...